Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001219036-12-000002)

Filing Details

Accession Number:: 0001219036-12-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-02-02 16:12:50
Reporting Period:: 2011-12-09

Filing Date:: 2012-02-02
Accepted Time:: 2012-02-02 16:12:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899923	Myriad Genetics Inc	MYGN	In Vitro & In Vivo Diagnostic Substances (2835)	870494517

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219036	S Jerry Lanchbury	320 Wakara Way Salt Lake City UT 84108	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-12-09	466	$0.00	28,735	No	4	G	Direct
Common Stock	Disposition	2012-02-01	6,000	$24.15	22,735	No	4	D	Direct
Common Stock	Acquisiton	2012-02-01	21,804	$8.63	44,539	No	4	M	Direct
Common Stock	Disposition	2012-02-01	21,804	$24.05	22,735	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Direct
No	4	D	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-02-01	21,804	$0.00	21,804	$8.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2016-02-16	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.
The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.